Please register or login to view the chart

Diabetes-Alphabet Strategy

Alphabet strategy for diabetes care

Advice-Smoking cessation physical activity diet weight control – aim for 5-10 % loss / year if over weight. Structured education- especially- 
 self-management beliefs knowledge skills driving occupation Regular follow up with Care Planning Annual Review is essential


 20 % with early severe complications will be persistent Diabetes Clinic non-attenders Ramadan advice Advice DiabetesUK membership.

Physical activity –choose activities that are enjoyed and fit into daily activities atleast 150 minutes ( 2 hrs 30 minutes ) of moderate intensity activity across the week or combinations of moderate and vigorous intensity activity resistance physical activity to improve muscle strength atleast two days a week minimize being sedentary ( sitting )

Weight management –encourage overweight and obese people to gradually reduce calorie intake
 explain 5-10 % weight loss in 1 year is a realistic initial target
 use evidence based behaviour-change techniques
 motivate and support to achieve and maintain – a healthy BMI
○ gen population 18.5- to 24.9
○ S Asian or Chinese descent 18.5 to 22.9 kg/m²
 Orlistat is an option

dietary advice- advice the right amount of calories for the level of activity ; daily usually
○ men 2500 kcals
○ women 2000 kcals many adults / some children may have too many calories usually from carbohydrates or fats
Ensure protein intake adequate
satiety: protein > fat > carbs Ensure >= 5 fruit & veg/spaced out through the day cut down on sugars carbs : more complex fat – cut down on total fat particularly saturated fat and partially replace with unsaturated fats ( sats to < 30g men, 20g women ) salt < 6 g/day do not confuse thirst with hunger smaller regular meals do not skip breakfast

Metformin- HbA1c rising despite participation intensive lifestyle program or unable to participate
 particularly if BMI > 35
 explain long -term lifestyle change can be more effective in preventing or delaying T2DM
 cont lifestyle advice
 check renal function before Rx , then x 2 yearly or more
 start low dose e.g 500 mg od , increase to 1500-2000 mg / daily
 if intolerant , consider metformin MR prescribe for 6-12 months
 monitor HbA1c or fasting plasma glucose at 3- month intervals and stop the drug if no effect

Orlistat- use clinical judgement on whether to offer orlistat if 
BMI > = 28.0 kg/m²
 discuss benefit and side effects
 advice low fat diet 
( < 30 % daily average as fat , over 3 main meals )
 review use after 12 weeks -if weight loss not atleast 5 % – stop treatment
 use orlistat for > 12 months only after discussing benefits & side effects

Diabetes remission protocol ( direct study ) If diabetes duration < 6 yrs : 830 kcal diet for around 12 weeks ( caliries from : protein 26 % , fat 13 % , carbs 61 % ). Then 400 kcal. meals reintroduced. Vitamins and minerals replete. Off all anti-diabetic and anti-hypertensive Rx. Optimal Physical Activity advised ( ideally 15000 steps/ day ). Relapse with weight gain treated 86 % chance of remission at 1 year if >= 15 kg weight loss. 57 % remission if 10-15 kg weight loss

Blood pressure –National Diabetes Audit target < 140/80 , <= 130/80 if kidney, eye damage or any CVD (A ) ie
ACEi or ARB Ca² blocker 
( C ) or
 D 
( indpamide ) 

CKD Prevention Micro Alb ACEi or ARB Ramipril 10 mg/ day shows 
○ stroke reduction , MACE and mortality reduction by 24 % Proteinuria 20-18 % reduction death / ESRD 
( losartan 100 mg od )

Cholesterol-National diabetes audit 
< 5 mmol/l
 NICE > 40 % reduction in non-HDL Chol Atorvastatin 20 mg od if > 40 yrs or duration > 10 yrs or established nephropathy or other CVD risk factors
 Atorvastatin 20 mg od if >= 10 % , 10 yr CVD risk on QRisk2 Atorvastatin 80 mg od
 CVD ( MI , angina , stroke , TIA , PVD ) initiate lower dose if older , low muscle mass , impaired renal function pr patient preference ) Atorvastatin 20 mg
 if > 40 % reduction in non-HDL C not achieved , increase dose Agree use of high-dose statin with renal specialist if eGFR < Ezetimibe 10 mg and / or Fenofibrate 160 mg / 200 mg may be useful in statin intolerance to reach targets
 Hydrophilic Pravastatin and Rosuvastatin less SEs ( simvastatin SE profile ↑ed with amlodipine , diltiazem , verampamil , > 250 ml of grapefruit juice daily )

Diabetes control – Diabetes control : Individually – agreed targets
NDA HbA1c <= 58 mmol/ ( 7.5 % )Type 2 initial treatment
○ Lifestyle -optimal diet , weight , physical activity

○ Metformin
500 mg bd
850 mg bd
1000 mg bd ( usual doses )
Consider B12 check
 First intensification – individualised to patient

If non- obese SU e.g gliclazide
start low dose e.g 40 mg od then titrate e.g 80 mg bd , 160 mg bd max
Note- hypo risk
If obese – DPP-4i ( weight neutral ) or
SGLT-2i ( weight loss )

If CKD adjust dose ( except linagliptin 5 mg )
Pioglitazone or GLP-1 RA sc also options
Consider insulin if ketones high , loosing weight , marked symptoms & glucose > 15 mmol/l or high HbA1c ( > 86 mmol/mol )
 Type 2 second intensification : Individualized to patient : Use appropriate 3rd line from above choices
 Type 3rd third intensification : individualised to patient- appropriate agent from above ? insulin ? GLP-1 agonist sc
Insulin regimes : NPH , glargine , levemir , degludec , toujeo overnight , biphasic bd , basal bolus regimes

GLP-1 agonists : Exanetide ( bd or once weekly ) liraglutide od , Lixisenatide od , dulaglutide ( once weekly ) in Hba1c >= 7.5 %. Consider instead of insulin or TZD in BMI >=35 , if problems with incd weight , occupation issues , insulin unacceptable or weight loss would benefit co-morbidities
Consider stopping unless HbA1c % >= 1 % better and >= 3 % weight loss in 6 months
 New Type 2 Guidelines : EASD / ADA guidance : If clinical CVD SGLT-2i or GLP-1RA with proven CV benefit is recommended . If CKD or clinical heart failure and atherosclerotic CVD a SGLT-2i inhibitor with proven benfit is recommended. GLP-1 RA is are generally recommended as first line injectible Rx

eye screening –BP & glycemic control esential Screen annually using a digital retinal camera Aspirin / ACE-i / ARB in most patients with retinopathy Consider fenofibrate – some evidence of reduced need for laser Rx in diagnosed retinopathy
Several national units use it for maculopathy 
( FIELD Study reduction in retinal laser and other outcomes by 34 % )

Foot care- All risk factors to be controlled aggressively Inspection , pedal pulses , 10 Mg MF testing If neuropathic or ischaemic , foot care advice and regular podiatry review is essential to prevent ulceration / amputation In the FIELD study there was a 36 % reduction in amputation using fenofibrate 160 mg od ? consider in individual cases with previous amputation ?

Guardian drugs-Aspirin 75 mg od when bp < 150 systolic : in any atheromatous CVD
 Clopidogrel 75 mg if further atheroma events on aspirin or aspirin intolerance
 ACEi reduce complications – Ramipril 10 mg od consider for most diabetics 
( Best evidence in type 2 diabetes )
 ARB Microalbuminuria
( best evidence : Irbesartan 300 mg od ) also if ACE not tolerated.
Proteinuria to retard progression to death and ESRD ( best evidence Losartan 100 mg od )

Chart reproduced with kind permission of Professor Vinod Patel MD FRCP FHEA MRCGP DRCOG MB ChB BSc ( Hons ) Professional Clinical Teaching Fellow : Diabetes and Clinical Skills Warwick Medical School University of Warwick Hon Consultant in Endocrinology and Diabetes , Diabetes and Endocrinology Centre George Eliot Hospital NHS Trust Nuneaton

Share

Related Charts:

Add Your Comments

Your email address will not be published. Required fields are marked *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

A4 Medicine  - Search Less and Learn More

Welcome to the A4 medicine community where we are constantly working to provide exceptional educational material to primary health care professionals. Subscribe to our website for complete access to our A4 Charts. They are aesthetically designed charts that contain 300 (plus and adding) common and complex medical conditions with the all information required for primary care in one single page that can help you in consultation/practice and exam.

Additionally, you will get complete access for our Learn From Experts : A4 Webinar Series in which domain experts share the video explainer presentation on one medical condition in one hour for the primary care. And you will also get a hefty discount on our publications and upcoming digital products.

We are giving a lifetime flat 30% discount to our first thousand users, discount code already applied to checkout.

Subscribe or Register